Paroxysmal Nocturnal Hemoglobinuria (PNH)
Michael Drazer, MD, PhD
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition
Crovalimab Crovalimab: An experimental complement inhibitor C5 monoclonal antibody.
Oral complement factor D inhibitor danicopan for paroxysmal nocturnal hemoglobinuria
Introduction: Paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal he
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria
Crovalimab Crovalimab: An experimental complement inhibitor C5 monoclonal antibody.
Aplastic Anemia, MDS, PNH Virtual Support Group-Saturdays-2024-December
AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare and serious co
Family/Caregiver Virtual Support Group - 2024 December
AAMDSIF is pleased to announce that we will host a support group for those caregiving for patients diagnosed with aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh)
Pediatric Parents Virtual Support Group - 2026 - February
This virtual support group is designed to support pediatric parents whose children have been diagnosed with aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_mee-uh) A rare
